Malaria prophylaxis policy for travellers from Europe to the Indian Sub Continent -: art. no. 7

被引:28
作者
Behrens, RH [1 ]
Bisoffi, Z
Björkman, A
Gascon, J
Hatz, C
Jelinek, T
Legros, F
Mühlberger, N
Voltersvik, P
机构
[1] Hosp Trop Dis, London NW1 0PE, England
[2] London Sch Hyg & Trop Med, London WC1, England
[3] Osped S Cuore, Ctr Malattie Trop, Negrar Verona, Italy
[4] Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden
[5] IDIBAPS, Hosp Clin, Ctr Salut Int, Barcelona, Spain
[6] Swiss Trop Inst, CH-4002 Basel, Switzerland
[7] Inst Trop Med, Berlin, Germany
[8] Haukeland Univ Hosp, Gade Inst, N-5021 Bergen, Norway
关键词
Malaria; Malaria Case; Vivax Malaria; Proguanil; Surveillance Body;
D O I
10.1186/1475-2875-5-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Analysis of malaria imported into eight European countries from the Indian sub-continent (ISC) (India, Pakistan, Bangladesh and Sri Lanka) led to a consensus statement on the use of chemoprophylaxis within TropNetEurop. The proportion of cases from the ISC in 2004 ranged from 1.4%-4.6% of total imported cases. Plasmodium falciparum cases reported from the eight countries was only 23 (13% of all cases from the region). Total malaria reports between 1999-2004 fell from 317 to 180. The risk of malaria in UK residents visiting the region was > 1 case per 1,000 years exposed. The group recommended non-selective prescribing of chemoprophylaxis for visitors to India, Pakistan, Bangladesh and Sri Lanka should be dropped.
引用
收藏
页数:4
相关论文
共 6 条
[1]  
Hatz C, 2005, B BUNDESAMTES GESUND, V9, P138
[2]   Epidemiology and clinical features of vivax malaria imported to Europe:: Sentinel surveillance data from TropNetEurop -: art. no. 5 [J].
Mühlberger, N ;
Jelinek, T ;
Gascon, J ;
Probst, M ;
Zoller, T ;
Schunk, M ;
Beran, J ;
Gjorup, I ;
Behrens, RH ;
Clerinx, J ;
Björkman, A ;
McWhinney, P ;
Matteelli, A ;
Lopez-Velez, R ;
Bisoffi, Z ;
Hellgren, U ;
Puente, S ;
Schmid, ML ;
Myrvang, B ;
Holthoff-Stich, ML ;
Laferl, H ;
Hatz, C ;
Kollaritsch, H ;
Kapaun, A ;
Knobloch, J ;
Iversen, J ;
Kotlowski, A ;
Malvy, DJM ;
Kern, P ;
Fry, G ;
Siikamaki, H ;
Schulze, MH ;
Soula, G ;
Paul, M ;
Prat, JGI ;
Lehmann, V ;
Bouchaud, O ;
da Cunha, S ;
Atouguia, J ;
Boecken, G .
MALARIA JOURNAL, 2004, 3 (1)
[3]  
Rombo L, 2005, J TRAVEL MED, V12, P217, DOI 10.2310/7060.2005.12408
[4]   Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study [J].
Schlagenhauf, P ;
Tschopp, A ;
Johnson, R ;
Nothdurft, HD ;
Beck, B ;
Schwartz, E ;
Herold, M ;
Krebs, B ;
Veit, O ;
Allwinn, R ;
Steffen, R .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7423) :1078-+
[5]  
*SWED REF GROUP MA, 2004, SMITTSKYDD S5, V3, P1
[6]   Knowledge, attitudes and practices in travel-related infectious diseases:: The European airport survey [J].
Van Herck, K ;
Castelli, F ;
Zuckerman, J ;
Nothdurft, H ;
Van Damme, P ;
Dahgren, AL ;
Gargalianos, P ;
Lopéz-Vélez, R ;
Overbosch, D ;
Caumes, E ;
Walker, E ;
Gisler, S ;
Steffen, R .
JOURNAL OF TRAVEL MEDICINE, 2004, 11 (01) :3-8